JamalG.MislehMD

PubMed

• Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies.
  Xu, L., Shadman, M., Flinn, I., Levy, M., Porter, R., Burke, J., Zafar, S., Cultrera, J., Misleh, J., Kingsley, E., Yimer, H., Freeman, B., Chaudhry, A., Tumula, P., G...> ;Haematologica. 2024 Jan 25
• Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
  Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William J Edenfield, Elizabeth Claire Dees, ...> ;Cancer Research Communications. 2023 Jul 1
• 6 citations
  Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
  Tomlins, S., Khazanov, N., Bulen, B., Hovelson, D., Shreve, M., Lamb, L., Matrana, M., Burkard, M., Yang, E., Edenfield, W., Dees, E., Onitilo, A., Thompson, M., Buchs...> ;Communications Medicine. 2023 Feb 7
• 19 citations
  Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single...
  Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan F Porter, John M Burke, Syed F Zafar, Jamal Misleh, Edwin C Kingsley, Habte A Yimer, Benjamin Freeman, Subramanya S Rao...> ;The Lancet. Haematology. 2023 Jan 1
• Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer.
  Magnuson, A.,Lei, L.,Gilmore, N.,Kleckner, A. S.,Lin, F. V.,Ferguson, R.,Hurria, A.,Wittink, M. N.,Esparaz, B. T.,Giguere, J. K.,Misleh, J.,Bautista, J.,Mohile, S. G.,...> ;J Am Geriatr Soc. 2019 Apr 30
• Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study.
  Yao, S.,Hu, Q.,Kerns, S.,Yan, L.,Onitilo, A. A.,Misleh, J.,Young, K.,Lei, L.,Bautista, J.,Mohamed, M.,Mohile, S. G.,Ambrosone, C. B.,Liu, S.,Janelsins, M. C.> ;Clin Epigenetics. 2019 Mar 15
• A Randomized, Double-Blind, Phase 2 Trial of Platinum Therapy plus Etoposide with or Without Concurrent Vandetanib (ZD6474) in Patients with Previously Untreated Exten...
  Nasser Hanna, Michael Guarino, Nagesh Jayaram, Gregory A Masters, Jamal Misleh, Anthony Stephens, Jyoti D Patel> ;Wiley.
• 17 citations
  Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma
  Thomas E. Witzig, Michael B Tomblyn, Jamal Misleh, Ebenezer A. Kio, Robert M. Sharkey, William A. Wegener, David M. Goldenberg> ;Haematologica. 2014 Nov 1
• 13 citations
  Multidisciplinary management of gastric cancer.
  Jamal Misleh, Peter Santoro, Jonathon F. Strasser, Joseph J. Bennett> ;Surgical Oncology Clinics of North America. 2013 Apr 1
• 37 citations
  Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.
  Brandon E. Kremer, Ran Reshef, Jamal G. Misleh, Jason D. Christie, Vivek N. Ahya, Nancy P. Blumenthal, Robert M. Kotloff, Denis Hadjiliadis, Edward A. Stadtmauer, Step...> ;The Journal of Heart and Lung Transplantation. 2012 Mar 1
• Rationing care: stifling progress while increasing cost of cancer care.
  Misleh, J.> ;Gastrointest Cancer Res. 2011 Sep
• Join now to see all